Companies: 10,795·Total market cap: $144.5T
Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc.

JSPRNASDAQHealthcare● Active
$0.47
$-0.02(-5.01%)
Market Cap$7606203
P/E Ratio
52W High$7.19
52W Low$0.43
Overview

Jasper Therapeutics, Inc. (JSPR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · JSPR · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.40jspr eps ttm · jspr earnings per shareEarnings history
PE Ratio (TTM)jspr pe ratio ttm · jspr price to earningsPE Ratio deep dive
Revenue (TTM)0.00jspr revenue ttm · jspr annual revenueFull revenue history
Dividend YieldNo Dividenddoes jspr pay dividends · jspr dividend yieldDividend history
Shares Outstanding19.2Mjspr shares outstanding · jspr floatShares outstanding history
Next EarningsAug 12, 2026Est.jspr earnings date · jspr next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
jasper therapeutics, inc. revenue · jspr revenue 2025
FY 2025Net Income-$75.8M▼ 6.36% YoY
202320242025
jasper therapeutics, inc. net income · jspr profit 2025
FY 2025EPS$-3.95▲ +19.22% YoY
202320242025
jspr eps · jasper therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$55.7MEPS: $-3.40View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy13 analystsis jspr a buy · jspr analyst rating
Strong Buy
0
Buy
8
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$3.00Low
$0.47Current
$3.00Avg Target541.03% upside
$3.00High
jspr price target · jspr 12 month forecast

Total: 13 · Buy rate: 61.5%

The JSPR analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +541.03% upside from the current price of $0.47.

Stock Performance

Full History
1D-5.01%
1W-15.29%
1M-49.48%
3M-66.09%
YTD-74.43%
1Y-92.12%
5Y-99.53%

About Jasper Therapeutics, Inc.

CEOJeetinder Singh Mahal
IPO DateJan 10, 2020
Employees64
CountryUS

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for hematopoietic stem cell transplantation and gene therapies. Its core mission is to develop and c…

what is jasper therapeutics, inc. · jspr stock overview · jasper therapeutics, inc. company profile · who is jasper therapeutics, inc. ceo · jspr NASDAQ · jasper therapeutics, inc. headquarters · jasper therapeutics, inc. business segments

About Stock Overview & Key Data

Jasper Therapeutics, Inc. (JSPR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 10, 2020. As of the latest trading session, JSPR stock price is $0.47, with a market capitalization of $7.6M. The stock has returned -92.12% over the past 12 months and -74.43% year-to-date.

According to 13 Wall Street analysts, the consensus rating for Jasper Therapeutics, Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Jasper Therapeutics, Inc. reported revenue of — and net income of -$75.8M. For detailed data — including Jasper Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Jasper Therapeutics, Inc. (JSPR) stock price is $0.47. The stock is traded on NASDAQ under the ticker symbol JSPR. The 52-week range is $0.43 – $7.19.

JSPR stock priceJSPR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice